HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
16 07 2020
Historique:
received: 10 03 2020
accepted: 11 05 2020
pubmed: 22 5 2020
medline: 20 11 2020
entrez: 22 5 2020
Statut: epublish

Résumé

If strategies currently in development succeed in eradicating HIV reservoirs in peripheral blood and lymphoid tissues, residual sources of virus may remain in anatomic compartments. Paired blood and semen samples were collected from 12 individuals enrolled in a randomized, double-blind, placebo-controlled therapeutic vaccine clinical trial in people with HIV (PWH) who began antiretroviral therapy (ART) during acute or early infection (ClinicalTrials registration no. NCT01859325). After the week 56 visit (postintervention), all participants interrupted ART. At the first available time points after viral rebound, we sequenced HIV-1

Identifiants

pubmed: 32434884
pii: JVI.00415-20
doi: 10.1128/JVI.00415-20
pmc: PMC7375368
pii:
doi:

Substances chimiques

Anti-Retroviral Agents 0
RNA, Viral 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI147821
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI131971
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118422
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI134295
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH062512
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH107345
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI131385
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD094646
Pays : United States
Organisme : NIDA NIH HHS
ID : DP2 DA051915
Pays : United States

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8869-73
pubmed: 9671771
Curr HIV Res. 2012 Mar;10(2):133-42
pubmed: 22329519
Curr Opin HIV AIDS. 2014 Nov;9(6):552-8
pubmed: 25203642
Infect Genet Evol. 2008 May;8(3):239-46
pubmed: 17921073
Mucosal Immunol. 2013 Jul;6(4):776-86
pubmed: 23187317
J Virol. 2001 Dec;75(23):11686-99
pubmed: 11689650
Infect Genet Evol. 2018 Nov;65:350-351
pubmed: 30118874
AIDS. 2019 Feb 1;33(2):279-284
pubmed: 30325777
J Virol. 2011 Aug;85(16):8359-67
pubmed: 21632754
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
J Infect Dis. 2006 Jan 1;193(1):45-8
pubmed: 16323130
AIDS. 2009 May 15;23(8):907-15
pubmed: 19414991
J Clin Invest. 2017 Jun 30;127(7):2689-2696
pubmed: 28628034
Nat Med. 2016 Sep;22(9):1043-9
pubmed: 27500724
Cell Rep. 2017 Oct 17;21(3):813-822
pubmed: 29045846
J Neurovirol. 2012 Apr;18(2):81-90
pubmed: 22528397
J Virol. 2005 Feb;79(3):1836-41
pubmed: 15650207
J Virol. 2011 Jun;85(12):6024-37
pubmed: 21471230
J Immunol. 2016 Jul 15;197(2):407-17
pubmed: 27382129
J Reprod Immunol. 2008 Jan;77(1):32-40
pubmed: 17395270
Curr Infect Dis Rep. 2014 Mar;16(3):392
pubmed: 24562540
MD Comput. 1997 Jul-Aug;14(4):306-17
pubmed: 9230594
Sci Transl Med. 2017 Dec 6;9(419):
pubmed: 29212716
J Virol. 1997 Jun;71(6):4761-70
pubmed: 9151870
J Virol. 2020 Jun 1;94(12):
pubmed: 32269124
Virus Evol. 2016 Aug 03;2(2):vew020
pubmed: 27774305
AIDS. 2010 Jun 19;24(10):1598-601
pubmed: 20549847
Mol Biol Evol. 1995 Sep;12(5):803-13
pubmed: 7476126
Nat Microbiol. 2019 Apr;4(4):633-644
pubmed: 30718846
J Virol. 2005 Feb;79(3):1734-42
pubmed: 15650198
Immunity. 2018 May 15;48(5):872-895
pubmed: 29768175
Virology. 2009 Nov 25;394(2):243-8
pubmed: 19762060
PLoS Pathog. 2013 Mar;9(3):e1003211
pubmed: 23516360
Elife. 2015 Dec 11;4:
pubmed: 26652000
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):95-102
pubmed: 27548440
Curr HIV/AIDS Rep. 2014 Jun;11(2):186-94
pubmed: 24729094
AIDS. 2017 Feb 20;31(4):477-484
pubmed: 28060012
PLoS Pathog. 2017 Jan 3;13(1):e1006112
pubmed: 28046096
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
AIDS. 2004 Nov 5;18(16):2202-5
pubmed: 15577656
J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):307-16
pubmed: 16249705
J Virol. 2007 Jun;81(12):6643-51
pubmed: 17428864
PLoS Comput Biol. 2010 Jan 29;6(1):e1000660
pubmed: 20126527
Genetics. 1989 Nov;123(3):603-13
pubmed: 2599370
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
Mol Biol Evol. 2005 Mar;22(3):478-85
pubmed: 15509724
Virology. 2009 Mar 1;385(1):204-8
pubmed: 19100592
J Virol. 2019 Aug 13;93(17):
pubmed: 31189714
AIDS. 2009 Sep 24;23(15):2050-4
pubmed: 19710596
J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34
pubmed: 16878047
J Clin Invest. 2020 Apr 1;130(4):1699-1712
pubmed: 31910162
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555
Science. 2009 Mar 6;323(5919):1304-7
pubmed: 19265012
Genetics. 1992 Jun;131(2):509-13
pubmed: 1644284

Auteurs

Sara Gianella (S)

University of California, San Diego, La Jolla, California, USA gianella@ucsd.edu.

Antoine Chaillon (A)

University of California, San Diego, La Jolla, California, USA.

Tae-Wook Chun (TW)

National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Michael C Sneller (MC)

National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Caroline Ignacio (C)

University of California, San Diego, La Jolla, California, USA.

Milenka V Vargas-Meneses (MV)

University of California, San Diego, La Jolla, California, USA.

Gemma Caballero (G)

University of California, San Diego, La Jolla, California, USA.

Ronald J Ellis (RJ)

University of California, San Diego, La Jolla, California, USA.

Colin Kovacs (C)

Maple Leaf Medical Clinic, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Erika Benko (E)

Maple Leaf Medical Clinic, Toronto, Ontario, Canada.

Sanja Huibner (S)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Rupert Kaul (R)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH